19021-35-3 Usage
Uses
Used in Pharmaceutical Industry:
4-amino-3-chloro-N,N-dimethyl-benzenesulfonamide is used as a chemical intermediate for the synthesis of various pharmaceuticals. Its presence in the structure allows for versatile chemical reactions, making it a valuable component in the development of new drugs.
Used in Dye and Pigment Manufacturing:
4-amino-3-chloro-N,N-dimethyl-benzenesulfonamide is used in the manufacturing of dyes and pigments due to its chemical properties. Its versatility in chemical reactions contributes to the production of a wide range of colorants for various applications.
Used in Antibacterial Applications:
4-amino-3-chloro-N,N-dimethyl-benzenesulfonamide has been studied for its potential antibacterial properties. It can be used as an active ingredient in the development of new antimicrobial agents to combat bacterial infections.
Used in Anti-inflammatory Applications:
4-amino-3-chloro-N,N-dimethyl-benzenesulfonamide has also been studied for its potential anti-inflammatory properties. It can be utilized in the development of anti-inflammatory drugs to treat various inflammatory conditions.
However, it is important to handle 4-amino-3-chloro-N,N-dimethyl-benzenesulfonamide with caution, as it can be harmful if ingested or inhaled, and exposure to skin and eyes should be avoided.
Check Digit Verification of cas no
The CAS Registry Mumber 19021-35-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,0,2 and 1 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 19021-35:
(7*1)+(6*9)+(5*0)+(4*2)+(3*1)+(2*3)+(1*5)=83
83 % 10 = 3
So 19021-35-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H11ClN2O2S/c1-11(2)14(12,13)6-3-4-8(10)7(9)5-6/h3-5H,10H2,1-2H3
19021-35-3Relevant academic research and scientific papers
PYRROLOPYRIDINEAMINO DERIVATIVES AS MPS1 INHIBITORS
-
Paragraph 0682-0683, (2014/02/15)
The present invention relates to the use of certain pyrrolopyridineamino derivatives (hereinafter referred to as “PPA derivatives”), particularly 1H-pyrrolo[3,2-c]pyridine-6-amino derivatives, to inhibit the spindle checkpoint function of Monospindle 1 (Mps1—also known as TTK) kinases either directly or indirectly via interaction with the Mps kinase itself. In particular, the present invention relates to PPA derivatives for use as therapeutic agents for the treatment and/or prevention of proliferative diseases, such as cancer. The present invention also relates to processes for the preparation of the PPA derivatives, and pharmaceutical compositions comprising them. Formula (I)
PYRROLOPYRIDINEAMINO DERIVATIVES AS MPS1 INHIBITORS
-
Page/Page column 88, (2012/10/07)
The present invention relates to the use of certain pyrrolopyridineamino derivatives (hereinafter referred to as "PPA derivatives"), particularly 1H-pyrrolo[3,2-c]pyridine-6- amino derivatives, to inhibit the spindle checkpoint function of Monospindle 1 (Mps1 – also known as TTK) kinases either directly or indirectly via interaction with the Mps kinase itself. In particular, the present invention relates to PPA derivatives for use as therapeutic agents for the treatment and/or prevention of proliferative diseases, such as cancer. The present invention also relates to processes for the preparation of the PPA derivatives, and pharmaceutical compositions comprising them. Formula (I)
